The information provided has been reviewed by licensed healthcare professionals but shouldn't replace a consultation with your physician
Oar Health was incubated by NewCo, a startup incubator backed by IAC/InterActiveCorp
Per the brand's own framing: People who want to support gut health as part of a broader wellness routine Anyone who'd rather try an over-the-counter option before considering prescription medication Anyone who doesn't have access to or doesn't qualify for prescription GLP-1 drugs Anyone who specifically wants a stimulant-free approach Who might it not fit
M., Cortet, B., Tournadre, A
Contrave's mechanism is more narrowly focused on central appetite regulation
The company claims its semaglutide drops, which are applied under the tongue, contain the same active ingredient found in Ozempic and Wegovy and provide the powerful benefits of GLP-1 without injections. EllieMD further touts, under a benefits tab on the drops product page, that the drops offer prescription appetite suppression and are scientifically backed to help users lose weight, adding that the drops can help to lower blood sugar levels and potentially reduce the risk factors associated with conditions like type 2 diabetes, high blood pressure and cardiovascular disease, which are often linked to diabetes. Meanwhile, a recent EllieMD Instagram post boasts about the cardiovascular benefits of its GLP-1 medication, including decreased risk of cardiovascular disease, heart attack and stroke
